CN Patent

CN115969833A — 胺碘酮药物组合物、注射液及其制备方法及含其的注射器

Assigned to Sph No1 Biochemical & Pharmaceutical Co ltd · Expires 2023-04-18 · 3y expired

What this patent protects

本发明公开了一种胺碘酮药物组合物、注射液及其制备方法及含其的注射器。该药物组合物包含药物活性成分、环糊精类化合物、助溶剂和水；所述药物活性成分为胺碘酮和/或在药物上可接受的胺碘酮盐；所述环糊精类化合物为环糊精和/或环糊精衍生物。该胺碘酮药物组合物的包合速度快，包含该药物组合物的胺碘酮注射剂中药物溶出速度高。

USPTO Abstract

本发明公开了一种胺碘酮药物组合物、注射液及其制备方法及含其的注射器。该药物组合物包含药物活性成分、环糊精类化合物、助溶剂和水；所述药物活性成分为胺碘酮和/或在药物上可接受的胺碘酮盐；所述环糊精类化合物为环糊精和/或环糊精衍生物。该胺碘酮药物组合物的包合速度快，包含该药物组合物的胺碘酮注射剂中药物溶出速度高。

Drugs covered by this patent

Patent Metadata

Patent number
CN115969833A
Jurisdiction
CN
Classification
—
Expires
2023-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Sph No1 Biochemical & Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.